×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
VTRS – viatris inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
VTRS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/29
01:41 pm
vtrs
Davis Opportunity Fund Annual Review 2026 [Seeking Alpha]
Low
Report
Davis Opportunity Fund Annual Review 2026 [Seeking Alpha]
1/24
07:11 pm
vtrs
Viatris (VTRS) Valuation Check After First International Inpefa Heart Failure Launch [Yahoo! Finance]
Low
Report
Viatris (VTRS) Valuation Check After First International Inpefa Heart Failure Launch [Yahoo! Finance]
1/24
01:53 am
vtrs
Is Viatris (VTRS) Pricing Reflect Its Recent Multi-Year Share Price Recovery [Yahoo! Finance]
Low
Report
Is Viatris (VTRS) Pricing Reflect Its Recent Multi-Year Share Price Recovery [Yahoo! Finance]
1/23
08:06 am
vtrs
Viatris Earnings Preview: What to Expect [Yahoo! Finance]
Low
Report
Viatris Earnings Preview: What to Expect [Yahoo! Finance]
1/23
12:05 am
vtrs
3 Reasons to Sell VTRS and 1 Stock to Buy Instead [Yahoo! Finance]
Low
Report
3 Reasons to Sell VTRS and 1 Stock to Buy Instead [Yahoo! Finance]
1/20
07:15 am
vtrs
Viatris Expands Innovative Portfolio in Cardiovascular Diseases with the Company's First Launch of Inpefa® (Sotagliflozin) for the Treatment of Heart Failure [Yahoo! Finance]
Low
Report
Viatris Expands Innovative Portfolio in Cardiovascular Diseases with the Company's First Launch of Inpefa® (Sotagliflozin) for the Treatment of Heart Failure [Yahoo! Finance]
1/20
06:59 am
vtrs
Viatris Expands Innovative Portfolio in Cardiovascular Diseases with the Company's First Launch of Inpefa® (Sotagliflozin) for the Treatment of Heart Failure
Low
Report
Viatris Expands Innovative Portfolio in Cardiovascular Diseases with the Company's First Launch of Inpefa® (Sotagliflozin) for the Treatment of Heart Failure
1/14
11:08 am
vtrs
"It Started With an Eye Exam" Campaign from Prevent Blindness Rolls Out in its Second Year to Share Stories on the Positive Impact of Access to Eye Care [Yahoo! Finance]
Low
Report
"It Started With an Eye Exam" Campaign from Prevent Blindness Rolls Out in its Second Year to Share Stories on the Positive Impact of Access to Eye Care [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/2
06:00 pm
vtrs
Form 4 Viatris Inc For: Jan 01 Filed by: Mistras Theodora
Low
Report
Form 4 Viatris Inc For: Jan 01 Filed by: Mistras Theodora
12/8
07:01 am
vtrs
Form 8-K Viatris Inc For: Dec 08
Low
Report
Form 8-K Viatris Inc For: Dec 08
12/5
04:19 pm
vtrs
Form 8-K Viatris Inc For: Dec 05
Low
Report
Form 8-K Viatris Inc For: Dec 05
12/5
04:16 pm
vtrs
Form 8-K/A Viatris Inc For: Aug 04
Low
Report
Form 8-K/A Viatris Inc For: Aug 04
11/10
09:03 am
vtrs
Form SCHEDULE 13G/A Viatris Inc Filed by: DAVIS SELECTED ADVISERS
Low
Report
Form SCHEDULE 13G/A Viatris Inc Filed by: DAVIS SELECTED ADVISERS
11/6
04:10 pm
vtrs
Form 10-Q Viatris Inc For: Sep 30
Low
Report
Form 10-Q Viatris Inc For: Sep 30
11/6
07:53 am
vtrs
Form 8-K Viatris Inc For: Nov 06
Medium
Report
Form 8-K Viatris Inc For: Nov 06
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: